Skip to content

Effectiveness of Tuina therapy in patients with chronic fatigue syndrome: a randomized controlled clinical trial

Clinical efficacy of Tuina therapy for chronic fatigue syndrome and its regulatory effects on the brain-gut mechanisms of tryptophan metabolism

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002204
Enrollment
Unknown
Registered
2025-11-17
Start date
2025-11-30
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic fatigue syndrome

Interventions

Sponsors

Shuguang Hospital affiliated to Shanghai University of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1)Age range from 20 to 60 years old regardless of gender; (2)According to the consensus on CFS diagnosis established by IOM; (3)Right-handed; (4)A change in bowel habits within the past month, including frequency, consistency, or defecation process; specifically, =3 bowel movements per day or =3 per week. Diarrhea may be accompanied by symptoms such as abdominal cramping or urgency, while constipation may present as difficulty in defecation or a sensation of incomplete evacuation; (5)No use of any interventions that may affect study outcomes within the past month, including Western medicine, Chinese patent medicines, herbal decoctions, or acupuncture; (6)Normal language comprehension and communication abilities, with the capacity to understand and complete questionnaires; (7)Informed consent and voluntarily sign the Informed Consent Form.

Exclusion criteria

Exclusion criteria: (1)Fatigue symptoms do not result in substantial impairment in occupational functioning, education, social activities, recreational activities, or activities of daily living; (2)Presence of severe dysfunction in vital organs, including the heart, brain, liver, or kidney;History of tumors, neurological disorders, or active infections; (3)Diagnosed psychiatric disorders or major depressive disorder, defined as a Self-Rating Depression Scale (SDS) score = 63; (4)Pregnant or planning to become pregnant, or currently breastfeeding; (5)Contraindications to magnetic resonance imaging (MRI), such as the presence of a cardiac pacemaker, neurostimulator, metallic implants or foreign bodies (e.g., intrauterine device), or insulin pump; (6)Severely obese individuals: Body Mass Index (BMI) > 45, BMI = weight (kg) / height (m)²; (7)Other conditions deemed inappropriate for participation in this study by the researchers.

Design outcomes

Primary

MeasureTime frame
Fatigue Scale-14;

Secondary

MeasureTime frame
36-Item Short Form Health Survey;Visual Analogue Scale ;Pittsburgh Sleep Quality Index ;Self-Rating Anxiety Scale;Self-Rating Depression Scale;Gastrointestinal Symptom Rating Scale;Bristol stool typing scale;Hand Grip Strength Test;

Countries

China

Contacts

Public ContactWenzonglin

Shuguang Hospital Shanghai University of Traditional Chinese Medicine

shuguangtuinawzl@163.com18818273239

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 14, 2026